Cours Merck & Co., Inc. Euronext Paris
Actions
MRK
US58933Y1055
Produits pharmaceutiques
CA 2024 * | 64,13 Md 59,15 Md 58,62 Md | CA 2025 * | 68,61 Md 63,27 Md 62,71 Md | Capitalisation | 328 Md 302 Md 300 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 19,51 Md 17,99 Md 17,83 Md | Résultat net 2025 * | 22,25 Md 20,52 Md 20,33 Md | VE / CA 2024 * | 5,4 x |
Dette nette 2024 * | 18,6 Md 17,15 Md 17 Md | Dette nette 2025 * | 7,29 Md 6,72 Md 6,66 Md | VE / CA 2025 * | 4,89 x |
PER 2024 * |
16,8
x | PER 2025 * |
14,5
x | Employés | 71 000 |
Rendement 2024 * |
2,39% | Rendement 2025 * |
2,53% | Flottant | 70,77% |
Dernier transcript sur Merck & Co., Inc.
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Robert Davis
CEO | Chief Executive Officer | 57 | 01/04/14 |
Director of Finance/CFO | 55 | 01/01/90 | |
Dave Williams
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/08/20 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Tom Glocer
BRD | Director/Board Member | 63 | 27/11/07 |
Pamela Craig
BRD | Director/Board Member | 67 | 01/09/15 |
Inge Thulin
BRD | Director/Board Member | 69 | 01/03/18 |
Nom | PEA | Position | Varia. 1 janv. | Notation |
---|---|---|---|---|
BRANDES US VALUE I USD ACC | Non | 29.03M USD | +6,00% | |
AMUNDI ACTIONS USA ISR P C | Non | 25.82M EUR | +14,00% | |
BGF WORLD HEALTHSCIENCE A2 | Non | 525.58M USD | -2,00% | |
AXAWF II NORTH AMERICAN EQS A DIS USD | Non | 3.77M USD | +15,00% | |
BELFIUS EQUITIES GLOB HEALTH CARE C$ CAP | Non | 23M USD | -3,00% |
Varia. 1 janv. | Capi. | |
---|---|---|
+38,51% | 727 Md | |
+33,05% | 599 Md | |
-6,23% | 354 Md | |
+1,35% | 277 Md | |
+16,00% | 243 Md | |
+8,09% | 205 Md | |
-5,77% | 203 Md | |
+6,19% | 164 Md | |
+0,31% | 164 Md |